Patents by Inventor Glenn R. Gibson

Glenn R. Gibson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220016149
    Abstract: The present invention provides a method for the prevention of the incidence of and/or a reduction in the duration of acute diarrhoea, particularly in travellers, said method comprising orally administering an oligosaccharide composition, in particular a non-digestible oligosaccharide, to a mammal.
    Type: Application
    Filed: July 19, 2021
    Publication date: January 20, 2022
    Inventors: Georgios TZORTZIS, Glenn R. GIBSON
  • Patent number: 11065268
    Abstract: The present invention provides a method for the prevention of the incidence of and/or a reduction in the duration of acute diarrhoea, particularly in travelers, said method comprising orally administering an oligosaccharide composition, in particular a non-digestible oligosaccharide, to a mammal.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: July 20, 2021
    Assignee: CLASADO RESEARCH SERVICES LIMITED
    Inventors: Georgios Tzortzis, Glenn R. Gibson
  • Patent number: 8557320
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Grant
    Filed: September 4, 2012
    Date of Patent: October 15, 2013
    Assignee: Mead Johnson Nutrition Company
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20120328585
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Application
    Filed: September 4, 2012
    Publication date: December 27, 2012
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Patent number: 8313789
    Abstract: A method of promoting the growth of beneficial bacteria in the gut of a human in need thereof, which involves administering to a human a composition containing an effective amount of Ara-(1-5)-(Ara)n-(1-5)-Ara as a prebiotic, where n=0-18.
    Type: Grant
    Filed: May 26, 2010
    Date of Patent: November 20, 2012
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Arland T. Hotchkiss, Alberto Nunez, Robert A. Rastall, Glenn R. Gibson
  • Patent number: 8277863
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: October 2, 2012
    Assignee: Mead Johnson Nutrition Company
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Patent number: 8241658
    Abstract: The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: August 14, 2012
    Assignee: Nestec S.A.
    Inventors: Glenn R. Gibson, Sofia Kolida
  • Publication number: 20120157406
    Abstract: The present invention provides a method for the prevention of the incidence of and/or a reduction in the duration of acute diarrhoea, particularly in travellers, said method comprising orally administering an oligosaccharide composition, in particular a non-digestible oligosaccharide, to a mammal.
    Type: Application
    Filed: May 27, 2009
    Publication date: June 21, 2012
    Inventors: Georgios Tzortzis, Glenn R. Gibson
  • Patent number: 8021708
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Grant
    Filed: February 12, 2009
    Date of Patent: September 20, 2011
    Assignee: Mead Johnson Nutrition Company
    Inventors: Byron W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20110021417
    Abstract: The present invention concerns compositions comprising a saccharide for the inhibition of pathogen adhesion to mammalian cells.
    Type: Application
    Filed: September 1, 2010
    Publication date: January 27, 2011
    Inventors: Jonathan Robert RHOADES, Robert Rastall, Glenn R. Gibson
  • Publication number: 20110003768
    Abstract: The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhoea and constipation.
    Type: Application
    Filed: July 19, 2010
    Publication date: January 6, 2011
    Inventors: Glenn R. GIBSON, Sofia Kolida
  • Publication number: 20100316766
    Abstract: A method of promoting the growth of beneficial bacteria in the gut of a human in need thereof, which involves administering to a human a composition containing an effective amount of Ara-(1-5)-(Ara)n-(1-5)-Ara as a prebiotic, where n=0-18.
    Type: Application
    Filed: May 26, 2010
    Publication date: December 16, 2010
    Inventors: Arland T. Hotchkiss, Alberto Nunez, Robert A. Rastall, Glenn R. Gibson
  • Patent number: 7842678
    Abstract: The present invention concerns compositions comprising a saccharide for the inhibition of pathogen adhesion to mammalian cells.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: November 30, 2010
    Assignee: Nestec S.A.
    Inventors: Jonathan R Rhoades, Robert Rastall, Glenn R. Gibson
  • Patent number: 7794746
    Abstract: The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: September 14, 2010
    Assignee: Nestec S.A.
    Inventors: Glenn R. Gibson, Sofia Kolida
  • Publication number: 20090311379
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Application
    Filed: July 2, 2009
    Publication date: December 17, 2009
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20090176734
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Application
    Filed: February 12, 2009
    Publication date: July 9, 2009
    Applicant: Mead Johnson & Co.
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Patent number: 7125708
    Abstract: A novel probiotic strain termed Lactobacillus pentosus NCIMB 41114 is capable of preventing growth of pathogenic microorganisms in the GI tract. In particular, this bacterium inhibits Candida overgrowth, and can be employed to prevent and treat associated diseases, including IBS and thrush.
    Type: Grant
    Filed: October 11, 2002
    Date of Patent: October 24, 2006
    Assignee: University of Reading, School of Food Biosciences
    Inventors: Anthony G. Wynne, Glenn R. Gibson, Jonathan Brostoff
  • Publication number: 20040131659
    Abstract: The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhoea and constipation.
    Type: Application
    Filed: November 25, 2003
    Publication date: July 8, 2004
    Inventors: Glenn R. Gibson, Sofia Kolida